The use of macrolides in respiratory tract infections
- 31 December 1993
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 3, S53-S61
- https://doi.org/10.1016/0924-8579(93)90035-4
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United StatesAntimicrobial Agents and Chemotherapy, 1992
- Antimicrobial Resistance in Streptococcus pneumoniae: An Epidemiological Survey in France, 1970-1990Clinical Infectious Diseases, 1992
- Clinical evaluation of roxithromycin 300 mg once daily as an alternative to 150 mg twice dailyDiagnostic Microbiology and Infectious Disease, 1992
- Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycinDiagnostic Microbiology and Infectious Disease, 1992
- The activity of azithromycin in animal models of infectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Spectrum of activity of azithromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Comparative in vitro activities of new 14-, 15-, and 16-membered macrolidesAntimicrobial Agents and Chemotherapy, 1988
- Erythromycin for treatment and prevention of pertussisThe Pediatric Infectious Disease Journal, 1986
- Broad host range of streptococcal macrolide resistance plasmidsAntimicrobial Agents and Chemotherapy, 1984
- Postantibiotic Suppression of Bacterial GrowthClinical Infectious Diseases, 1981